AstraZeneca $402 million deal gives boost to C4X Discovery shares
-Shares gain 35% on exclusive $402 million license-Win-win deal for both companies-COPD market worth around $20 billionDrug discovery company C4X Discovery (C4XD:AIM) has signed an exclusive global licensing agreement with...
28 November 2022